CONMED CORP (CNMD) Stock Price & Overview

NYSE:CNMD • US2074101013

Current stock price

39.31 USD
+0.85 (+2.21%)
Last:

The current stock price of CNMD is 39.31 USD. Today CNMD is up by 2.21%. In the past month the price increased by 3.17%. In the past year, price decreased by -20.85%.

CNMD Key Statistics

52-Week Range33.21 - 61.08
Current CNMD stock price positioned within its 52-week range.
1-Month Range33.21 - 38.6
Current CNMD stock price positioned within its 1-month range.
Market Cap
1.212B
P/E
8.53
Fwd P/E
8.85
EPS (TTM)
4.61
Dividend Yield
2.17%

CNMD Stock Performance

Today
+2.21%
1 Week
+12.85%
1 Month
+3.17%
3 Months
-7.48%
Longer-term
6 Months -14.89%
1 Year -20.85%
2 Years -43.42%
3 Years -69.37%
5 Years -72.71%
10 Years -7.15%

CNMD Stock Chart

CONMED CORP / CNMD Daily stock chart

CNMD Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to CNMD. When comparing the yearly performance of all stocks, CNMD is a bad performer in the overall market: 82.47% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CNMD Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to CNMD. CNMD has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CNMD Earnings

On January 28, 2026 CNMD reported an EPS of 1.43 and a revenue of 373.20M. The company beat EPS expectations (5.94% surprise) and missed revenue expectations (-0.25% surprise).

Next Earnings DateApr 29, 2026
Last Earnings DateJan 28, 2026
PeriodQ4 / 2025
EPS Reported$1.43
Revenue Reported373.198M
EPS Surprise 5.94%
Revenue Surprise -0.25%

CNMD Forecast & Estimates

11 analysts have analysed CNMD and the average price target is 45.08 USD. This implies a price increase of 14.69% is expected in the next year compared to the current price of 39.31.

For the next year, analysts expect an EPS growth of -3.63% and a revenue growth -0.72% for CNMD


Analysts
Analysts50.91
Price Target45.08 (14.68%)
EPS Next Y-3.63%
Revenue Next Year-0.72%

CNMD Groups

Sector & Classification

CNMD Financial Highlights

Over the last trailing twelve months CNMD reported a non-GAAP Earnings per Share(EPS) of 4.61. The EPS increased by 10.82% compared to the year before.


Income Statements
Revenue(TTM)1.37B
Net Income(TTM)47.05M
Industry RankSector Rank
PM (TTM) 3.42%
ROA 2.02%
ROE 4.55%
Debt/Equity 0.81
Chartmill High Growth Momentum
EPS Q2Q%6.72%
Sales Q2Q%7.88%
EPS 1Y (TTM)10.82%
Revenue 1Y (TTM)5.18%

CNMD Ownership

Ownership
Inst Owners112.85%
Shares30.83M
Float30.65M
Ins Owners0.28%
Short Float %7.28%
Short Ratio4.7

About CNMD

Company Profile

CNMD logo image CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. The company is headquartered in Largo, Florida and currently employs 3,900 full-time employees. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.

Company Info

IPO: 1987-07-23

CONMED CORP

11311 Concept Boulevard

Largo FLORIDA 33773 US

CEO: Curt R. Hartman

Employees: 3900

CNMD Company Website

CNMD Investor Relations

Phone: 17272142974

CONMED CORP / CNMD FAQ

What does CONMED CORP do?

CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. The company is headquartered in Largo, Florida and currently employs 3,900 full-time employees. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.


Can you provide the latest stock price for CONMED CORP?

The current stock price of CNMD is 39.31 USD. The price increased by 2.21% in the last trading session.


What is the dividend status of CONMED CORP?

CONMED CORP (CNMD) has a dividend yield of 2.17%. The yearly dividend amount is currently 0.8.


How is the ChartMill rating for CONMED CORP?

CNMD has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the employee count for CNMD stock?

CONMED CORP (CNMD) currently has 3900 employees.


Can you provide the market cap for CONMED CORP?

CONMED CORP (CNMD) has a market capitalization of 1.21B USD. This makes CNMD a Small Cap stock.


When does CONMED CORP (CNMD) report earnings?

CONMED CORP (CNMD) will report earnings on 2026-04-29, after the market close.